VaramirStart free · no cardSign in
ALT as of Nov 1 · 12:42 ET
ALTNasdaqPharmaceutical Preparations

Altimmune, Inc. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±11.5%
avg realized
±9.5%
Nov 12 '24±12.4%▲+29.12%×2.35
Feb 27 '25±8.2%▲+8.08%×0.99
May 13 '25±15.6%▼−4.16%×0.27
Aug 12 '25±10.1%▲+7.10%×0.70
Q3 FY25±14.3%▲+5.07%×0.36
Q1 FY26±10.3%▼−17.92%×1.74
May 13 '26±8.2%▼−1.95%×0.24
Q2 FY26±12.7%▼−2.33%×0.18
quarterimplied−30%0+30%realized×
Q2 FY26±12.7%▼−2.33%×0.18
May '26±8.2%▼−1.95%×0.24
Q1 FY26±10.3%▼−17.92%×1.74
Q3 FY25±14.3%▲+5.07%×0.36
Aug '25±10.1%▲+7.10%×0.70
May '25±15.6%▼−4.16%×0.27
2 older reports
Feb '25±8.2%▲+8.08%×0.99
Nov '24±12.4%▲+29.12%×2.35
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 4

4tracked funds holding ALTN-PORT · Aug 31 '26
211managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

0.23%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
6 of 8recent reports where the move came in under the options-implied rangeEarnings history
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ALT report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±67.5% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.